Novavax developing joint COVID/flu vaccine
Vaccine manufacturer Novavax has announced it is developing a joint COVID-19/flu shot that is currently in the trial stage. Novavax already manufactures flu shots and a COVID-19 vaccine, which has not yet been approved for public use in Australia.
However, the government has placed an order for 51 million doses.
View the full story here: https://www.9news.com.au/world/coronavirus-vaccine-updates-novavax-developing-joint-flu-covid-19-vaccine/e0dd13b4-26ca-4416-9b43-9cce0e0468aa